A Snapshot of Antimicrobial Resistance in Mexico. Results from 47 Centers from 20 States During a Six-month Period

Material And Methods: In this retrospective study, we included a stratified sample of 47 centers, covering 20 Mexican states. Selected isolates considered as potential causatives of disease collected over a 6-month period were included. Laboratories employed their usual methods to perform microbiological studies. The results were deposited into a database and analyzed with the WHONET 5.6 software.

Results: In this 6-month study, a total of 22,943 strains were included. Regarding Gram-negatives, carbapenem resistance was detected in ≤ 3% in Escherichia coli, 12.5% in Klebsiella sp. and Enterobacter sp., and up to 40% in Pseudomonas aeruginosa; in the latter, the resistance rate for piperacillin-tazobactam (TZP) was as high as 19.1%. In Acinetobacter sp., resistance rates for cefepime, ciprofloxacin, meropenem, and TZP were higher than 50%. Regarding Gram-positives, methicillin resistance in Staphylococcus aureus (MRSA) was as high as 21.4%, and vancomycin (VAN) resistance reached up to 21% in Enterococcus faecium. Acinetobacter sp. presented the highest multidrug resistance (53%) followed by Klebsiella sp. (22.6%) and E. coli (19.4%).

Conclusion: The multidrug resistance of Acinetobacter sp., Klebsiella sp. and E. coli and the carbapenem resistance in specific groups of enterobacteria deserve special attention in Mexico. Vancomycin-resistant enterococci (VRE) and MRSA are common in our hospitals. Our results present valuable information for the implementation of measures to control drug resistance.

Citing Articles

Complications Beyond Borders: A Case Study on a Retained Surgical Towel Leading to an Intra-abdominal Abscess Post-hysterectomy.

Judd D, Hawes J, Oldham J, Stucki B, Boyack DO B Cureus. 2024; 16(10):e72601.

PMID: 39610575 PMC: 11604235. DOI: 10.7759/cureus.72601.

Interesting Cytokine Profile Caused by Clinical Strains of MDR Carrying the exoU Gene.

Badillo-Larios N, Turrubiartes-Martinez E, Layseca-Espinosa E, Gonzalez-Amaro R, Perez-Gonzalez L, Nino-Moreno P Int J Microbiol. 2024; 2024:2748842.

PMID: 38974708 PMC: 11227949. DOI: 10.1155/2024/2748842.

Antibiotic resistance of ESKAPE group-microorganisms in health institutions from Hermosillo and Ciudad Obregón, Sonora, México.

Alvarez-Ainza M, Fong-Coronado P, Ruiz-Bustos E, Castillon-Campana L, Quintero-Reyes I, Duarte-Zambrano L Front Cell Infect Microbiol. 2024; 14:1348093.

PMID: 38516533 PMC: 10955632. DOI: 10.3389/fcimb.2024.1348093.

Antimicrobial Resistance and Antibiotic Consumption in a Secondary Care Hospital in Mexico.

Davila-Lopez E, Berumen-Lechuga M, Molina-Perez C, Jimenez-Juarez R, Leanos-Miranda A, Robles-Ordonez N Antibiotics (Basel). 2024; 13(2).

PMID: 38391564 PMC: 10886054. DOI: 10.3390/antibiotics13020178.

Active Surveillance of Antimicrobial Resistance and Carbapenemase-Encoding Genes According to Sites of Care and Age Groups in Mexico: Results from the INVIFAR Network.

Rojas-Larios F, Martinez-Guerra B, Lopez-Jacome L, Bolado-Martinez E, Vazquez-Larios M, Velazquez-Acosta M Pathogens. 2023; 12(9).

PMID: 37764952 PMC: 10537696. DOI: 10.3390/pathogens12091144.

References

Reinert R, Low D, Rossi F, Zhang X, Wattal C, Dowzicky M . Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline. J Antimicrob Chemother. 2007; 60(5):1018-29. DOI: 10.1093/jac/dkm310. View

Ponce-de-Leon A, Rodriguez-Noriega E, Morfin-Otero R, Cornejo-Juarez D, Tinoco J, Martinez-Gamboa A . Antimicrobial susceptibility of gram-negative bacilli isolated from intra-abdominal and urinary-tract infections in Mexico from 2009 to 2015: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). PLoS One. 2018; 13(6):e0198621. PMC: 6013120. DOI: 10.1371/journal.pone.0198621. View

Morfin-Otero R, Rodriguez-Noriega E, Deshpande L, Sader H, Castanheira M . Dissemination of a bla(VIM-2)-carrying integron among Enterobacteriaceae species in Mexico: report from the SENTRY Antimicrobial Surveillance Program. Microb Drug Resist. 2009; 15(1):33-5. DOI: 10.1089/mdr.2009.0878. View

Magiorakos A, Srinivasan A, Carey R, Carmeli Y, Falagas M, Giske C . Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2011; 18(3):268-81. DOI: 10.1111/j.1469-0691.2011.03570.x. View

Rice L . Progress and challenges in implementing the research on ESKAPE pathogens. Infect Control Hosp Epidemiol. 2010; 31 Suppl 1:S7-10. DOI: 10.1086/655995. View

Kunz A, Brook I . Emerging resistant Gram-negative aerobic bacilli in hospital-acquired infections. Chemotherapy. 2010; 56(6):492-500. DOI: 10.1159/000321018. View

Gould I . The epidemiology of antibiotic resistance. Int J Antimicrob Agents. 2008; 32 Suppl 1:S2-9. DOI: 10.1016/j.ijantimicag.2008.06.016. View

Rice L . Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis. 2008; 197(8):1079-81. DOI: 10.1086/533452. View

Molina-Lopez J, Aparicio-Ozores G, Ribas-Aparicio R, Gavilanes-Parra S, Chavez-Berrocal M, Hernandez-Castro R . Drug resistance, serotypes, and phylogenetic groups among uropathogenic Escherichia coli including O25-ST131 in Mexico City. J Infect Dev Ctries. 2011; 5(12):840-9. DOI: 10.3855/jidc.1703. View

10.

Slama T . Gram-negative antibiotic resistance: there is a price to pay. Crit Care. 2008; 12 Suppl 4:S4. PMC: 2391261. DOI: 10.1186/cc6820. View

11.

Bocanegra-Ibarias P, Garza-Gonzalez E, Morfin-Otero R, Barrios H, Villarreal-Trevino L, Rodriguez-Noriega E . Molecular and microbiological report of a hospital outbreak of NDM-1-carrying Enterobacteriaceae in Mexico. PLoS One. 2017; 12(6):e0179651. PMC: 5479539. DOI: 10.1371/journal.pone.0179651. View

12.

Mosqueda-Gomez J, Montano-Loza A, Rolon A, Cervantes C, Bobadilla-Del-valle J, Silva-Sanchez J . Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae A case-control study. Int J Infect Dis. 2008; 12(6):653-9. DOI: 10.1016/j.ijid.2008.03.008. View

13.

Barrios H, Silva-Sanchez J, Reyna-Flores F, Sanchez-Perez A, Sanchez-Francia D, Aguirre-Torres J . Detection of a NDM-1-producing Klebsiella pneumoniae (ST22) clinical isolate at a pediatric hospital in Mexico. Pediatr Infect Dis J. 2014; 33(3):335. DOI: 10.1097/INF.0000000000000173. View

14.

Zaidi M, Estrada-Garcia T, Campos F, Chim R, Arjona F, Leon M . Incidence, clinical presentation, and antimicrobial resistance trends in Salmonella and Shigella infections from children in Yucatan, Mexico. Front Microbiol. 2013; 4:288. PMC: 3787544. DOI: 10.3389/fmicb.2013.00288. View

15.

Morfin-Otero R, Tinoco-Favila J, Sader H, Salcido-Gutierrez L, Perez-Gomez H, Gonzalez-Diaz E . Resistance trends in gram-negative bacteria: surveillance results from two Mexican hospitals, 2005-2010. BMC Res Notes. 2012; 5:277. PMC: 3407022. DOI: 10.1186/1756-0500-5-277. View

16.

Johnson J, Johnston B, Clabots C, Kuskowski M, Castanheira M . Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis. 2010; 51(3):286-94. DOI: 10.1086/653932. View

17.

Walker R, Duggin G . Drug nephrotoxicity. Annu Rev Pharmacol Toxicol. 1988; 28:331-45. DOI: 10.1146/annurev.pa.28.040188.001555. View

18.

Reyna-Flores F, Barrios H, Garza-Ramos U, Sanchez-Perez A, Rojas-Moreno T, Uribe-Salas F . Molecular epidemiology of Escherichia coli O25b-ST131 isolates causing community-acquired UTIs in Mexico. Diagn Microbiol Infect Dis. 2013; 76(3):396-8. DOI: 10.1016/j.diagmicrobio.2013.03.026. View

19.

Nelson R, Slayton R, Stevens V, Jones M, Khader K, Rubin M . Attributable Mortality of Healthcare-Associated Infections Due to Multidrug-Resistant Gram-Negative Bacteria and Methicillin-Resistant Staphylococcus Aureus. Infect Control Hosp Epidemiol. 2017; 38(7):848-856. DOI: 10.1017/ice.2017.83. View

20.

Bassetti M, Ginocchio F, Mikulska M . New treatment options against gram-negative organisms. Crit Care. 2011; 15(2):215. PMC: 3219411. DOI: 10.1186/cc9997. View